IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#478
Positioning
Market Dominance
Manufacturing
Medical Equipment
$22.0B
Roy Jakobs
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, including magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions.
Headcount
78.2K
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = PHG ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$PHG KONINKLIJKE PHILIPS NV | 62 | 73 | 60 | 51 | - | 16.1x | -23.3% | -9.6% | 43.1% | 5.3% | -3.9% | -7.2% | 0.0% | 64.0x | $22.0B | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
KONINKLIJKE PHILIPS NV (PHG) receives a "Hold" rating with a composite score of 62.3/100. It ranks #478 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Roy Jakobs
Chief Executive Officer
Labor Force
78,200
73
38
75
Audit Verdict: Average governance indicators based on financial metrics.
No recent insider transactions available for PHG
HQ Base
Eindhoven,
In-line with peers — no strong momentum signal
Fair valuation relative to peers
High profitability & efficiency — strong quality floor supports entry
Low volatility — smoother ride and historically better risk-adjusted returns
Moderate investment profile
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for PHG.
View All RatingsImproving capital utilization rates confirmed
High margin volatility — erratic forensic earnings quality
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 73 | 81 | -8DRAG |
| MOMENTUM | 51 | 39 | +12ALPHA |
| VALUATION | 60 | 43 | +17ALPHA |
| INVESTMENT | 38 | 66 | -28DRAG |
| STABILITY | 75 | 73 | +2NEUTRAL |
| SHORT INT | 76 | 87 | -11DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC 8.0% vs WACC 8.2% (spread -0.3%)
GM 43% vs sector 43%, OM 5% vs sector 1%
Capital turnover 3.44x, R&D intensity 9.7%
Rev growth -7%, 8yr history
Interest coverage 2.2x, Net debt/EBITDA 9.9x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our model assigns KONINKLIJKE PHILIPS NV a Hold rating, with a composite score of 62.3/100 and 3 out of 5 stars. Ranked #478 of 7,333 stocks, PHG presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
PHG earns a quality score of 73/100, indicating above-average business quality. The company reports a return on equity of -23.3% (sector avg: -2.5%), gross margins of 43.1% (sector avg: 42.5%), net margins of -3.9% (sector avg: -0.2%). Companies in this tier generally demonstrate consistent profitability and efficient capital deployment, though they may face some competitive pressure.
PHG's value score of 60/100 indicates the stock is fairly valued based on its current fundamentals. Key valuation metrics include an EV/EBITDA of 16.05x, a P/B ratio of 2.39x. At this level, neither a clear bargain nor overpriced, the stock's attractiveness depends more on forward growth expectations and qualitative factors.
KONINKLIJKE PHILIPS NV's investment score of 38/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -7.2% vs. a sector average of 5.9% and a return on assets of -9.6% (sector: -0.1%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
PHG demonstrates moderate momentum with a score of 51/100, suggesting a neutral price trend without strong directional conviction. Revenue growth stands at -7.2% year-over-year, while a beta of 0.93 reflects its sensitivity to broader market moves. Moderate momentum may indicate the stock is consolidating or transitioning between trends, warranting close monitoring of upcoming catalysts.
PHG shows good financial stability with a score of 75/100. Key stability metrics include a beta of 0.93 and a debt-to-equity ratio of 64.00x (sector avg: 0.2x). This suggests manageable leverage and moderate price volatility, making it appropriate for investors seeking a balance between growth potential and capital preservation.
PHG carries a short interest score of 76/100, indicating moderate short selling activity. This is a neutral reading — not enough to signal systemic bearishness, but worth monitoring. Specific risk factors include elevated leverage (D/E: 64.00x). At $22.0B market cap (large-cap), KONINKLIJKE PHILIPS NV offers reasonable institutional liquidity.
KONINKLIJKE PHILIPS NV is a large-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #478 of 7,333 overall (93rd percentile). Key comparisons include ROE of -23.3% trailing the -2.5% sector median and operating margins of 5.3% above the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While PHG currently exhibits a HOLD profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Upgrade catalyst
Investment (38) is the limiting factor — improvement here would lift the composite score most.
EV/EBITDA 40% ABOVE SECTOR MEDIAN
ROE 838% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin IN LINE WITH SECTOR BENCHMARKS
AUDIT DATA AS OF DEC 31, 2024 (Q3 FY2024)
We rate KONINKLIJKE PHILIPS NV (PHG) as a Hold with a composite score of 62.3/100 at a current price of $31.50. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling for existing holders. Our factors are split, and the overall profile suggests patience is warranted.
The rating is primarily driven by strength in stability (75th percentile) and quality (73th percentile), which together account for the majority of the composite score. Offsetting weakness in investment (38th percentile) and momentum (51th percentile) tempers our overall conviction. We assign a No Moat rating (33/100), High uncertainty, and Poor capital allocation.
Key items to watch: the path to profitability. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
KONINKLIJKE PHILIPS NV holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 62.3/100 places it at rank #478 in our full 7,333-stock universe. With a $22.0B market capitalization, KONINKLIJKE PHILIPS NV operates at meaningful scale within the Manufacturing sector, providing competitive advantages in distribution, procurement, and customer reach.
Revenue contraction of -7% combined with momentum at the 51th percentile paints a cautious picture of the near-term business outlook. The market appears to be pricing in continued challenges, and a catalyst for reversal is not clearly visible from current data.
The margin cascade tells an important story: gross margins of 43% (+0.6pp vs sector) narrow to operating margins of 5% (+4.0pp vs sector) and net margins of -3.9%, yielding a gross-to-net conversion rate of -9%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $31.50, KONINKLIJKE PHILIPS NV is trading near fair value based on current fundamentals. Our value factor score of 60/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. Valuation metrics are mixed, with no strong signal of mispricing in either direction.
The stock currently trades at EV/EBITDA of 16.1x (at a premium), P/B of 2.4x, P/S of 0.4x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
Gross margins of 43% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
Revenue decline of -7% signals business deterioration — declining revenues make it difficult to grow into the current valuation and often precede further negative revisions.
Thin net margins of -3.9% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
Elevated short interest (76th percentile) indicates that sophisticated market participants are betting against the stock.
We assign a High uncertainty rating to KONINKLIJKE PHILIPS NV. Key risk factors include current negative profitability (net margin -3.9%), the combination of leverage (64% D/E) and thin margins (-3.9% net) amplifies downside risk. The wide range of potential outcomes widens our fair value estimate and increases the possibility of permanent capital impairment. Investors considering this name should size positions accordingly and demand a meaningful margin of safety before initiating.
Specific risk factors that inform our assessment include: current negative profitability (net margin -3.9%); the combination of leverage (64% D/E) and thin margins (-3.9% net) amplifies downside risk. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 75th percentile and quality factor at the 73th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 43% provide a buffer against cost pressures; above-average stability (75th percentile) suggests predictable business dynamics. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile warrants caution and disciplined position management.
We rate KONINKLIJKE PHILIPS NV's capital allocation as Poor. Key concerns include low returns on equity (-23.3%), negative profitability, weak asset returns (ROA -9.6%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — KONINKLIJKE PHILIPS NV significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, KONINKLIJKE PHILIPS NV receives a Hold rating with a composite score of 62.3/100 (rank #478 of 7,333). Our quantitative framework assigns a No Moat (33/100, trend: stable), High uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 59/100.
Our analysis supports a neutral stance on KONINKLIJKE PHILIPS NV. While the quantitative profile is not weak enough to warrant selling, it lacks the multi-factor strength required for a buy recommendation. Existing holders should maintain positions and monitor for catalysts — either fundamental improvement or valuation compression — that would shift the risk-reward balance.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign KONINKLIJKE PHILIPS NV a meaningful economic moat, scoring 33/100 on our composite assessment. The ROIC-WACC spread of -0.3% is the primary signal of economic value creation. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, margin superiority, reached only 13.5/20.
The strongest moat sources are margin superiority (13.5/20) and reinvestment efficiency (9.4/20). GM 43% vs sector 43%, OM 5% vs sector 1%. Capital turnover 3.44x, R&D intensity 9.7%. These pillars form the core of KONINKLIJKE PHILIPS NV's competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include growth durability (2.6/20) and financial resilience (3.2/20). Rev growth -7%, 8yr history. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect KONINKLIJKE PHILIPS NV's moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 43% providing a solid profitability foundation, declining revenues (-7%) that pressure the earnings outlook. The margin cascade from 43% gross to 5% operating to -3.9% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that the profit engine is high-quality and likely sustainable, with the quality factor at the 73th percentile.
The margin profile shows gross margins of 43%, operating margins of 5%, net margins of -3.9%. Return metrics include ROE of -23.3% and ROA of -9.6%. Relative to the Manufacturing sector, gross margins are 0.6 percentage points above the sector median of 43%, and ROE of -23.3% compares to a sector median of -2.5%.
The balance sheet reflects moderate leverage with D/E of 64%, revenue growth of -7%. The sector median D/E is 0%, putting KONINKLIJKE PHILIPS NV at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
Above 50MA
37.18%
Net New Highs
+51081
Danaher (NYSE:DHR) has entered a definitive agreement to acquire health tech firm Masimo. The deal will bring Masimo into Danaher as a standalone operating unit within its diagnostics-focused portfolio. The transaction is positioned as a material move for Danaher’s presence in patient monitoring and clinical diagnostics. For you as an investor, this deal sits at the intersection of medical technology and diagnostics, two areas that continue to attract attention from large healthcare groups...

The article highlights Taiwan Semiconductor Manufacturing (TSM) as a critical but overlooked player in the global AI revolution. Founded in 1987 by Morris Chang, TSM pioneered the foundry-based semiconductor business model, allowing design companies to specialize while TSM handled manufacturing. The company has become essential to major tech firms and benefits from long-term trends like digital transformation, cloud computing, and artificial intelligence.
ResMed is expanding its U.S. distribution network with a new facility in Greenwood, Indiana. The center is intended to support North American logistics, delivery coverage, and job creation. The move is aimed at strengthening supply chain capacity and responsiveness to patient demand across the region. For investors watching NYSE:RMD, this operational update comes alongside a share price of $260.79 and a 1 year return of 14.6%. Over 3 and 5 years, the stock shows returns of 26.6% and 39.2%,...
Panasonic abandons TV manufacturing to Chinese partner Skyworth in 2026, ending Japanese TV production as cost pressures force brand licensing survival.
Top Dems are expected to skip his speech but invited Epstein accusers and ICE detainees in their place